<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Department of Obstetrics and Gynecology

School of Medicine

Nanette Santoro, MD, Highlights Findings on Fezolinetant From Pooled Analysis of Phase 3 Skylight Development Program Trials

Default sub title

minute read

by Patient Care | May 19, 2025
placeholder

Related Articles

OB-GYN Education

Fellowships

Residency

Clerkship

Academic Calendar

Annual Conferences

OB-GYN Divisions

Academic Specialists in OB-GYN

Community OB-GYN Medicine

Family Planning

Gynecologic Oncology

Maternal-Fetal Medicine

Reproductive Endocrinology and Infertility

Reproductive Sciences

Urogynecology and Reconstructive Pelvic Surgery

About Us

Our Faculty

Our Research

Our Staff

Patient Care

For Patients

CU Family Planning

CU Fertility Preservation and Reproductive Late Effects Program

CU Gynecologic Oncology

CU Maternal-Fetal Medicine

CU Medicine OB-GYN East Denver (Rocky Mountain)

CU Medicine OB-GYN – Highlands Ranch (5280 OB-GYN)

CU Medicine OB-GYN – South Metro

CU OB-GYN

CU Pediatric and Adolescent Gynecology

CU Urogynecology

© 2025  The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.